Intellia Therapeutics (NTLA) Misses Q2 EPS by 8c, beats revenue

Go back to Intellia Therapeutics (NTLA) Misses Q2 EPS by 8c, beats revenue
(NASDAQ: NTLA) Delayed: 12.09 +0.07 (0.58%)
Previous Close $12.02    52 Week High $30.40 
Open $12.06    52 Week Low $11.86 
Day High $12.31    P/E N/A 
Day Low $11.88    EPS $0.00 
Volume 2,041,961